Cabinet approves PLI scheme for pharmaceuticals

By: |
February 24, 2021 4:53 PM

The government on Wednesday approved Production Linked Incentive (PLI) scheme for pharmaceuticals, and said the move will bring investments of Rs 15,000 crore into the sector.

The PLI scheme for pharma is expected to promote the production of high-value products in the country and increase the value addition in exports.

The government on Wednesday approved Production Linked Incentive (PLI) scheme for pharmaceuticals, and said the move will bring investments of Rs 15,000 crore into the sector. The scheme will benefit domestic manufacturers, spur job opportunities and contribute to availability of wider range of affordable medicines for consumers. It is expected to bring in investment of Rs 15,000 crore in the pharmaceutical sector, an official release said.

The PLI scheme for pharma is expected to promote the production of high-value products in the country and increase the value addition in exports. Total incremental sales of Rs 2,94,000 crore and incremental exports to the tune of Rs 1,96,000 crore are expected during six years from 2022-23 to 2027-28, the release added.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Nazara to acquire majority stake in Publishme for Rs 20 cr
2Microsoft names India-born CEO Satya Nadella as company’s Chairman
3IKEA enters Bengaluru with eCommerce and mobile shopping app